This seminar will discuss what to consider and how to best prepare for premarket notification 510(k)s for submission to the FDA. The speaker will walk you through how to format a new, succinct and comprehensive 510(k) package/dossier to increase submission quality and to facilitate the review process in a streamlined manner.
You will leave the workshop empowered in preparing for your next 510(k) submissions.
In 1976, the Medical Device Amendments (MDAs) to the Federal Food, Drug, and Cosmetic Act (FDCA or the Act) created the concept of 510(k) program. Under section 510(k) of the Act, device manufacturers are required to notify FDA of their intent at least 90 days prior to marketing a medical device in the US.
A premarket notification [510(k)] is the most common regulatory pathway to bring some medical devices into the US market.
The 510(k) is made to the US Food and Drug Administration (FDA) to demonstrate that the subject device (to be marketed) is substantially equivalent (as least as safe and effective) to a legally marketed device (predicate device).
This seminar will discuss what to consider and how to best prepare for the 510(k) submission package including dos and don’ts while ensuring 510(k) submission quality to prevent avoidable mistakes and delays and saving significant resources.
It is imperative that medical device industry quickly recognize the recent changes in the 510(k) process, and understand and adapt to the recent changes/requirements.
·
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). Dr. Lim is a leading industry speaker and has presented and addressed FDA regulatory and compliance matters in various forums and meetings.
Dr. Lim has helped both pharma and medical device industry for regulatory, clinical and compliance matters. Dr. Lim has also advised many firms including, but not limited to risk management firms, venture capital firms, asset management firms, and fund managers to make right investment decisions in view of FDA regulatory and compliance matters.
12:00 PM EST 11:00 AM CST 10:00 AM MST 09:00 AM PST